Filing Details
- Accession Number:
- 0000950170-25-081199
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-03 18:30:05
- Reporting Period:
- 2025-06-03
- Filing Date:
- 2025-06-03
- Accepted Time:
- 2025-06-03 18:30:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1815442 | Kymera Therapeutics Inc. | KYMR | Biological Products, (No Disgnostic Substances) (2836) | 812992166 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1821189 | Nello Mainolfi | C/O Kymera Therapeutics, Inc. 500 North Beacon Street, 4Th Floor Watertown MA 02472 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-06-03 | 30,000 | $2.08 | 690,482 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-06-03 | 30,000 | $49.00 | 660,482 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2025-06-03 | 30,000 | $0.00 | 30,000 | $2.08 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 465,559 | 2029-11-13 | No | 4 | M | Direct |
Footnotes
- These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 6, 2024 adopted by the reporting person.
- This number includes 523 shares acquired under the Registrant's employee stock purchase plan on June 2, 2025.
- The shares underlying this stock option are fully vested and exercisable.
Billionaire Hedge Funds
